Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.930
+0.170 (3.57%)
Aug 19, 2026, 12:35 PM EDT - Market open

Whitehawk Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-7.1525.9824.3515.221.12
Revenue Growth
--72.50%6.69%60.05%1258.57%-92.32%
Gross Profit
-63.49-84.58-28.07-27.38-18.78-18.55
Operating Income
-86.06-114.4-64.82-71.93-58.96-37.06
Net Income
-79.83-20.6-63.69-65.77-60.51-110.74
Earnings Per Share
-1.10-0.33-2.36-2.44-2.69-12.41
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
189.98145.747.24108.85172.56148.99
Total Debt
--0.831.271.660.61
Net Cash (Debt)
189.98145.746.4107.58170.9148.38
Net Cash Growth
7.21%213.97%-56.87%-37.05%15.17%-
Net Cash Per Share
2.612.351.724.007.5916.63

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-69.35-97.43-59.55-59.66-49.64-22.42
Capital Expenditures
--0.55-1.65-3.97-0.44-0.05
Free Cash Flow
-69.35-97.99-61.2-63.64-50.08-22.47
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---108.04%-112.44%-123.43%-
Operating Margin
--1601.12%-249.47%-295.36%-387.47%-3309.02%
Pretax Margin
--288.26%-245.13%-270.04%-397.69%-9829.29%
Profit Margin
--288.26%-245.13%-270.04%-397.69%-9887.23%
FCF Margin
--1371.38%-235.55%-261.29%-329.15%-2006.16%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-15.962.992.0320.57450.53